An Open Labelled, Randomized, Comparative Study Of Arjuna-Rasonadi yoga & Navaka guggulu On Medodushti With Special Reference To Dyslipidaemia

ational Institute Of Ayurveda deemed to be universityjaipur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•1 Willing to give written informed consent and willing to comply with trial protocol.
•2 Subjects in the age group of 18â??70 years of both genders.
•3 As per ATP III guidelines; baseline LDL ranging 160- 189mg/dl, TC >=200 mg/dL, TG ranging 150-199 mg/dL.
•4 Ability to understand the risks or benefits of the protocol.
•5 Subject should be available for duration of study period.

•1 Participants with chronic diseases requiring continuous use of vasoactive drugs, diuretics, lipid-lowering or anti-diabetic drugs.
•2 Subjects having history of diabetes (Type I or Type II) except other than the subject having the prediabetes condition with the random blood glucose 140-199 mg/dl.
•3 Subjects suffered from intractable obesity, had defined weight limits or had experienced any recent, unexplained weight loss or gain.
•4 Subjects having history of serious cardiovascular diseases such MI.
•5 Subjects having abnormal liver (ALT or AST) 2 times the upper limit of normal;
•6 Subjects having abnormal findings on complete blood count.
•7 Subjects having history of high alcohol intake (2 standard drinks per day).
•8 Subjects having history of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
•9 Any other condition that, in the opinion of the investigator, would adversely affect the subjectâ??s ability to complete the study or its measures.
•10 Subjects participated in any other clinical trials within thirty (30) days prior to screening.

发起方

ational Institute Of Ayurveda deemed to be universityjaipur